Treatment with corticosteroids
Cardiomyopathy - Treatment with corticosteroids Factor
Last reviewed for CCPS 18 July 2007.
Investigative Documents
Medical Report - Non-Topical Non-Inhaled Corticosteroids - Cardiomyopathy [MR9386]
Preliminary questions [38094]
there is some evidence that treatment with non-topical non-inhaled corticosteroids may be a factor in the development or worsening of the condition under consideration.38095 the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least three months at some time.
the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least three months for an illness or injury which is identifiable.38099 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for cardiomyopathy.
for the identified illness or injury, the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least the three months before the clinical onset of the condition under consideration.38100 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for the clinical onset of cardiomyopathy.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened. for the identified illness or injury, the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least the three months before the clinical worsening of the condition under consideration.38101 — the veteran has established the causal connection between treatment with non-topical non-inhaled corticosteroids and operational service for the clinical worsening of cardiomyopathy.
Clinical onset and operational service [38100]
38102 — the identified illness or injury, for which the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least three months, is causally related to operational service.
Clinical worsening and operational service [38101]
38102 — the identified illness or injury, for which the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least three months, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was treated with non-topical non-inhaled corticosteroids, at doses equivalent to at least 7.5 milligrams per day of prednisolone, for at least three months, is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/cardiomyopathy-g021-4254-425964866748/rulebase-cardiomyopathy/treatment-corticosteroids